| Metabolic plasticity of acute myeloid leukemia J Kreitz, C Schönfeld, M Seibert, V Stolp, I Alshamleh, T Oellerich, ... Cells 8 (8), 805, 2019 | 132 | 2019 |
| Real‐time NMR spectroscopy for studying metabolism I Alshamleh, N Krause, C Richter, N Kurrle, H Serve, UL Günther, ... Angewandte Chemie 132 (6), 2324-2328, 2020 | 40 | 2020 |
| Large-scale recombinant production of the SARS-CoV-2 proteome for high-throughput and structural biology applications N Altincekic, SM Korn, NS Qureshi, M Dujardin, M Ninot-Pedrosa, R Abele, ... Frontiers in molecular biosciences 8, 653148, 2021 | 39 | 2021 |
| Dietary methionine starvation impairs acute myeloid leukemia progression A Cunningham, A Erdem, I Alshamleh, M Geugien, M Pruis, ... Blood, The Journal of the American Society of Hematology 140 (19), 2037-2052, 2022 | 24 | 2022 |
| Comprehensive fragment screening of the SARS‐CoV‐2 proteome explores novel chemical space for drug development H Berg, MA Wirtz Martin, N Altincekic, I Alshamleh, J Kaur Bains, ... Angewandte Chemie International Edition 61 (46), e202205858, 2022 | 11 | 2022 |
| Metabolic plasticity is an essential requirement of acquired tyrosine kinase inhibitor resistance in chronic myeloid leukemia MGC Mostazo, N Kurrle, M Casado, D Fuhrmann, I Alshamleh, B Häupl, ... Cancers 12 (11), 3443, 2020 | 10 | 2020 |
| Metabolic rewiring is essential for AML cell survival to overcome autophagy inhibition by loss of ATG3 F Baker, IH Polat, K Abou-El-Ardat, I Alshamleh, M Thoelken, D Hymon, ... Cancers 13 (23), 6142, 2021 | 6 | 2021 |
| Synthesis and in Vitro Evaluation of Novel 5‐Nitroindole Derivatives as c‐Myc G‐Quadruplex Binders with Anticancer Activity VD Nimbarte, J Wirmer‐Bartoschek, SL Gande, I Alshamleh, M Seibert, ... ChemMedChem 16 (10), 1667-1679, 2021 | 3 | 2021 |
| Deuterium metabolic imaging differentiates glioblastoma metabolic subtypes and detects early response to chemoradiotherapy JCM Low, J Cao, F Hesse, AJ Wright, A Tsyben, I Alshamleh, R Mair, ... Cancer Research, 2024 | | 2024 |
| PDP1 is a key metabolic gatekeeper and modulator of drug resistance in FLT3-ITD-positive acute myeloid leukemia I Alshamleh, N Kurrle, P Makowka, R Bhayadia, R Kumar, S Süsser, ... Leukemia, 2023 | | 2023 |
| Investigating metabolic dependencies of acute myeloid leukaemia and state-of-the-art metabolomics development by NMR spectroscopy I Alshamleh University of Birmingham, 2022 | | 2022 |
